Conestoga Capital Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,718
| Closed | -$1.06M | – | 127 |
|
|
2023
Q1 | $1.06M | Hold |
90,718
| – | – | 0.02% | 90 |
|
|
2022
Q4 | $964K | Buy |
90,718
+12,410
| +16% | +$132K | 0.02% | 91 |
|
|
2022
Q3 | $760K | Hold |
78,308
| – | – | 0.01% | 101 |
|
|
2022
Q2 | $1.14M | Buy |
78,308
+17,808
| +29% | +$258K | 0.02% | 87 |
|
|
2022
Q1 | $1.58M | Sell |
60,500
-250,479
| -81% | -$6.55M | 0.02% | 80 |
|
|
2021
Q4 | $12.3M | Sell |
310,979
-5,065
| -2% | -$201K | 0.16% | 71 |
|
|
2021
Q3 | $15.8M | Sell |
316,044
-2,335
| -0.7% | -$117K | 0.22% | 70 |
|
|
2021
Q2 | $17.7M | Buy |
318,379
+24,135
| +8% | +$1.34M | 0.26% | 69 |
|
|
2021
Q1 | $13.8M | Buy |
294,244
+2,840
| +1% | +$133K | 0.21% | 68 |
|
|
2020
Q4 | $12.7M | Buy |
291,404
+13,760
| +5% | +$599K | 0.2% | 66 |
|
|
2020
Q3 | $10.2M | Buy |
277,644
+29,077
| +12% | +$1.06M | 0.21% | 65 |
|
|
2020
Q2 | $7.25M | Buy |
248,567
+31,225
| +14% | +$911K | 0.16% | 69 |
|
|
2020
Q1 | $5.68M | Buy |
217,342
+100,205
| +86% | +$2.62M | 0.17% | 65 |
|
|
2019
Q4 | $4.07M | Buy |
117,137
+14,447
| +14% | +$501K | 0.1% | 65 |
|
|
2019
Q3 | $3.25M | Buy |
+102,690
| New | +$3.25M | 0.08% | 67 |
|